Sample costs shipping and taxes has to be paid by the buyer
As per customer request
Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
Sorafinib - Api
Sorafenib, is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML and radioactive iodineresistant advanced thyroid carcinoma.
Molarmass: 464.825 g/mol
CAS ID: 284461-73-0
Other Products in 'API - Active Pharmaceutical Ingredients' category